Total planned funding: $1,231,087,894
Clear active filters
Chemonics International
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $233,431,787 |
Tanzania | $226,908,126 |
Zambia | $212,487,489 |
Mozambique | $124,414,048 |
Kenya | $83,614,933 |
Zimbabwe | $66,258,967 |
Uganda | $55,388,967 |
Rwanda | $46,891,480 |
Haiti | $39,516,349 |
Democratic Republic of the Congo | $36,383,897 |
Ethiopia | $25,797,961 |
South Africa | $16,476,885 |
Vietnam | $10,248,987 |
Ukraine | $9,101,684 |
Eswatini | $7,979,790 |
Malawi | $6,245,208 |
Lesotho | $6,000,000 |
Burundi | $4,621,159 |
Namibia | $4,119,487 |
Botswana | $3,197,753 |
Cameroon | $3,009,847 |
Angola | $2,250,000 |
Ghana | $2,021,918 |
Indonesia | $1,300,000 |
South Sudan | $1,137,111 |
Central America Region | $921,400 |
Caribbean Region | $512,660 |
Burma | $500,000 |
Cambodia | $350,000 |
Côte d'Ivoire | $1 |
Organizational Types
Private Contractor | $1,231,087,894 |
Program Areas
Treatment | $970,155,891 |
Care | $84,900,787 |
Testing | $64,574,502 |
Governance and Systems | $56,700,419 |
Prevention | $53,745,336 |
Budget Codes
HTXD: Treatment: ARV Drugs | $734,746,150 |
HTXS: Treatment: Adult Treatment | $219,655,178 |
HVCT: Testing: HIV Testing and Counseling | $64,574,502 |
OHSS: Health Systems Strengthening | $46,287,976 |
HBHC: Care: Adult Care and Support | $45,046,015 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $36,928,736 |
HVTB: Care: TB/HIV | $20,562,755 |
PDTX: Treatment: Pediatric Treatment | $15,754,563 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $11,489,074 |
PDCS: Care: Pediatric Care and Support | $10,510,969 |
HKID: Care: Orphans and Vulnerable Children | $8,781,048 |
HLAB: Laboratory Infrastructure | $7,647,421 |
HVOP: Sexual Prevention: Other Sexual Prevention | $3,121,546 |
HVSI: Strategic Information | $2,765,022 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $1,599,215 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $331,765 |
HMIN: Biomedical Prevention: Injection Safety | $275,000 |
HMBL: Biomedical Prevention: Blood Safety | $0 |
Top Partner Programs
Chemonics International:
$1,231,087,894
View countries